Lilly to Acquire Massachusetts Company

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is planning to acquire a biotechnology company headquartered in Massachusetts. The deal for Disarm Therapeutics, which is developing disease-modifying... Read More